- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
670
Companies which are more than 50% undervalued based on analyst price target.
670 companies
MediWound
Market Cap: US$182.3m
A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
MDWD
US$16.29
7D
-2.5%
1Y
-1.9%
Actuate Therapeutics
Market Cap: US$180.9m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$8.24
7D
-2.4%
1Y
1.1%
BICO Group
Market Cap: SEK 1.7b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 23.80
7D
1.0%
1Y
-45.3%
Diamyd Medical
Market Cap: SEK 1.7b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 12.14
7D
7.4%
1Y
-19.7%
Tiziana Life Sciences
Market Cap: US$176.1m
A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.
TLSA
US$1.66
7D
-8.3%
1Y
102.4%
MDxHealth
Market Cap: US$174.7m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$3.53
7D
-0.6%
1Y
24.7%
Milestone Pharmaceuticals
Market Cap: US$174.3m
A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
MIST
US$1.80
7D
-2.2%
1Y
23.3%
Ryvu Therapeutics
Market Cap: zł631.2m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł27.30
7D
-5.5%
1Y
-47.4%
Race Oncology
Market Cap: AU$265.8m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$1.53
7D
28.0%
1Y
-8.9%
Botanix Pharmaceuticals
Market Cap: AU$264.8m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.14
7D
-6.9%
1Y
-67.5%
Tevogen Bio Holdings
Market Cap: US$173.0m
A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
TVGN
US$0.87
7D
-4.8%
1Y
105.9%
Bioventix
Market Cap: UK£128.0m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£24.50
7D
-3.0%
1Y
-38.0%
Caribou Biosciences
Market Cap: US$172.3m
A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.
CRBU
US$1.87
7D
0%
1Y
8.7%
Adocia
Market Cap: €146.4m
A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
ADOC
€8.03
7D
-3.0%
1Y
47.1%
Transgene
Market Cap: €145.6m
A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.
TNG
€1.10
7D
-3.5%
1Y
-1.8%
Nuvectis Pharma
Market Cap: US$166.0m
A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
NVCT
US$6.68
7D
1.8%
1Y
8.1%
Black Diamond Therapeutics
Market Cap: US$163.4m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$2.94
7D
6.9%
1Y
-45.6%
Selvita
Market Cap: zł591.0m
Operates as a contract research organization worldwide.
SLV
zł32.20
7D
3.5%
1Y
-48.5%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 23.00
7D
-3.6%
1Y
-1.9%
Sangamo Therapeutics
Market Cap: US$160.0m
A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.
SGMO
US$0.55
7D
5.2%
1Y
-24.3%
Climb Bio
Market Cap: US$157.9m
A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.
CLYM
US$2.39
7D
7.2%
1Y
-67.7%
OSE Immunotherapeutics
Market Cap: €134.5m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.88
7D
-4.1%
1Y
-30.9%
Kyverna Therapeutics
Market Cap: US$157.0m
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.
KYTX
US$3.94
7D
6.2%
1Y
-46.3%
Eledon Pharmaceuticals
Market Cap: US$156.3m
Operates as a clinical stage biotechnology company.
ELDN
US$2.71
7D
4.6%
1Y
6.7%
Coherus Oncology
Market Cap: US$152.3m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.29
7D
11.2%
1Y
4.0%
Nkarta
Market Cap: US$151.3m
A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.
NKTX
US$2.26
7D
6.6%
1Y
-57.5%
Greenwich LifeSciences
Market Cap: US$149.5m
A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania.
GLSI
US$10.93
7D
-4.8%
1Y
-24.6%
Theratechnologies
Market Cap: CA$206.9m
A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.
TH
CA$4.53
7D
1.8%
1Y
174.5%
ABIONYX Pharma
Market Cap: €127.3m
A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
ABNX
€3.67
7D
7.6%
1Y
184.5%
T.Man Pharmaceutical
Market Cap: ฿4.8b
Manufactures and sells pharmaceuticals and health care products in Thailand.
TMAN
฿11.90
7D
4.4%
1Y
n/a
Inovio Pharmaceuticals
Market Cap: US$146.1m
A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.
INO
US$2.79
7D
17.7%
1Y
-55.6%
MaxCyte
Market Cap: US$145.0m
A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MXCT
US$1.41
7D
1.4%
1Y
-62.8%
Alpha Cognition
Market Cap: US$143.8m
A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.
ACOG
US$8.90
7D
7.2%
1Y
-14.3%
Achieve Life Sciences
Market Cap: US$142.6m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$2.83
7D
-5.0%
1Y
-32.1%
Cardiff Oncology
Market Cap: US$141.7m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$2.17
7D
3.3%
1Y
2.8%
Cybin
Market Cap: US$141.1m
A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
CYBN
US$6.73
7D
-10.0%
1Y
-15.7%